AU1750497A - Compounds capable of inhibiting hiv-1 infection - Google Patents

Compounds capable of inhibiting hiv-1 infection

Info

Publication number
AU1750497A
AU1750497A AU17504/97A AU1750497A AU1750497A AU 1750497 A AU1750497 A AU 1750497A AU 17504/97 A AU17504/97 A AU 17504/97A AU 1750497 A AU1750497 A AU 1750497A AU 1750497 A AU1750497 A AU 1750497A
Authority
AU
Australia
Prior art keywords
infection
compounds capable
inhibiting hiv
hiv
inhibiting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17504/97A
Inventor
Graham P. Allaway
Virginia M. Litwin
Paul J. Maddon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Progenics Pharmaceuticals Inc
Original Assignee
Progenics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenics Pharmaceuticals Inc filed Critical Progenics Pharmaceuticals Inc
Publication of AU1750497A publication Critical patent/AU1750497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU17504/97A 1996-01-17 1997-01-17 Compounds capable of inhibiting hiv-1 infection Abandoned AU1750497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58745896A 1996-01-17 1996-01-17
US587458 1996-01-17
PCT/US1997/000758 WO1997026009A1 (en) 1996-01-17 1997-01-17 Compounds capable of inhibiting hiv-1 infection

Publications (1)

Publication Number Publication Date
AU1750497A true AU1750497A (en) 1997-08-11

Family

ID=24349889

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17504/97A Abandoned AU1750497A (en) 1996-01-17 1997-01-17 Compounds capable of inhibiting hiv-1 infection

Country Status (2)

Country Link
AU (1) AU1750497A (en)
WO (1) WO1997026009A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637890D1 (en) 1995-06-07 2009-05-14 Progenics Pharm Inc MONOCLONAL ANTIBODY FOR THE INHIBITION OF HIV-1-HÜLLGYKOPROTEIN-MEDIATED MEMBRANE FUSION
US6265184B1 (en) 1995-12-20 2001-07-24 Icos Corporation Polynucleotides encoding chemokine receptor 88C
US7118859B2 (en) 1996-01-17 2006-10-10 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
US6528625B1 (en) 1996-10-28 2003-03-04 Millennium Pharmaceuticals, Inc. Anti-CCR5 antibodies and kits comprising same
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
FR2789590B1 (en) * 1999-02-15 2003-01-17 Inst Rech Developpement Ird IMMUNOGENIC COMPOSITIONS FOR USE AS VACCINES
US7138119B2 (en) 2000-09-15 2006-11-21 Progenics Pharmaceuticals, Inc. Compositions and methods for inhibition of HIV-1 infection
US7060273B2 (en) 2001-04-06 2006-06-13 Progenics Pharmaceuticals, Inc. Methods for inhibiting HIV-1 infection
AU2002320314A1 (en) 2001-07-05 2003-01-21 Chiron, Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US7122185B2 (en) 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody
CA2616189C (en) 2005-07-22 2019-03-26 Progenics Pharmaceuticals, Inc. Methods for reducing viral load in hiv-1-infected patients

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091513A (en) * 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
US5071964A (en) * 1988-05-04 1991-12-10 Dana-Farber Cancer Institute, Inc. Protein micelles

Also Published As

Publication number Publication date
WO1997026009A1 (en) 1997-07-24

Similar Documents

Publication Publication Date Title
AU5426096A (en) Uses of antibacterial compounds
AU2438297A (en) Combinations of angiostatic compounds
AU3390297A (en) Uses of a chemokine receptor for inhibiting hiv-1 infection
AU3634095A (en) Inhibition of hemoflagellates by camptothecin compounds
AU1067599A (en) Peptide compositions for the treatment and prevention of hiv infection
AU1408300A (en) Hiv infection inhibitors
AU6517396A (en) Preparation of N-substituted 3-hydroxypyrazoles
AU1750497A (en) Compounds capable of inhibiting hiv-1 infection
AU5237296A (en) Use of pyrrole compounds as antifouling agents
AU6564600A (en) Copolymers of acryloyloxyalkylamino compounds
AU2558797A (en) Purification of nitrile
AU6690300A (en) Copolymers of acryloylaminoalkyl compounds
AU1600597A (en) Stabilisation of polyolefin-recyclates
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU4917397A (en) Benzodiazepine hydrazide derivatives as inhibitors of hiv integrase
AU3191597A (en) Novel medicinal compositions of hydropyridines
AU2381995A (en) Methanol derivatives for treatment of retroviral infections especially hiv infections
IL116925A0 (en) Compounds for treating hiv infection
AU3554395A (en) Purification of stable organic compounds
AU4602897A (en) Method for treatment of immunodeficiency virus infection
AU5033296A (en) Antidepressant heteroarylaminoalkyl derivatives of naphthyl-monazines
AU5126298A (en) Inhibition of crib-biting
AU6442096A (en) Protection of trees
AU5622599A (en) Use of 5-amino-pyrazol-derivatives for combating micro-organisms
AU8102498A (en) Preparation of diaryl-benzopyrans